Rury R Holman Selected Research

Aspirin (Acetylsalicylic Acid)

1/2019	Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes.
9/2017	Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).
3/2009	Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rury R Holman Research Topics

Disease

107	Type 2 Diabetes Mellitus (MODY) 04/2024 - 02/2002
43	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 05/2002
29	Myocardial Infarction 01/2023 - 10/2008
28	Heart Failure 01/2023 - 12/2006
24	Stroke (Strokes) 01/2023 - 04/2010
23	Glucose Intolerance 11/2023 - 10/2006
12	Insulin Resistance 01/2023 - 10/2002
9	Atrial Fibrillation 01/2022 - 01/2012
9	Hypoglycemia (Reactive Hypoglycemia) 12/2019 - 02/2002
8	Hypertension (High Blood Pressure) 10/2023 - 11/2004
8	Unstable Angina 01/2023 - 04/2010
7	Coronary Disease (Coronary Heart Disease) 11/2023 - 09/2013
7	Hyperglycemia 01/2022 - 05/2002
7	Diabetes Mellitus 12/2019 - 07/2006
7	Weight Gain 01/2018 - 02/2002
5	Vascular Diseases (Vascular Disease) 07/2023 - 01/2016
5	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2023 - 11/2004
5	Body Weight (Weight, Body) 01/2022 - 02/2002
5	Renal Insufficiency (Renal Failure) 01/2020 - 06/2013
4	Overweight 01/2023 - 11/2006
4	Neoplasms (Cancer) 01/2022 - 11/2017
4	Blindness (Hysterical Blindness) 01/2020 - 06/2013
4	Obesity 01/2020 - 08/2006
4	Pancreatitis 01/2018 - 02/2017
3	Weight Loss (Weight Reduction) 01/2023 - 04/2015
3	Inflammation (Inflammations) 01/2023 - 01/2020
3	Chronic Renal Insufficiency 01/2022 - 11/2017
3	Peripheral Arterial Disease 10/2021 - 03/2009
3	Albuminuria 10/2021 - 06/2006
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2020 - 06/2006
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 02/2017
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 08/2006
2	Orthostatic Hypotension (Postural Hypotension) 10/2023 - 01/2021
2	Infections 10/2021 - 01/2020
2	Acute Coronary Syndrome 01/2021 - 01/2020
2	Edema (Dropsy) 01/2018 - 12/2006
2	Bone Fractures (Bone Fracture) 11/2017 - 01/2010
2	Eye Diseases (Eye Disease) 11/2017 - 07/2006
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 01/2017
2	Diabetes Complications 06/2013 - 11/2006
1	Hypotension (Low Blood Pressure) 10/2023
1	Vascular Calcification 07/2023
1	ST Elevation Myocardial Infarction 01/2023

Drug/Important Bio-Agent (IBA)

37	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 08/2002
25	Sitagliptin Phosphate (Januvia)FDA Link 01/2023 - 12/2013
20	Exenatide (Byetta)FDA Link 05/2023 - 04/2016
19	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 10/2002
15	Valsartan (Vals)FDA Link 10/2020 - 10/2008
14	Nateglinide (Starlix)FDA LinkGeneric 10/2020 - 10/2008
13	Insulin (Novolin)FDA Link 01/2022 - 02/2002
10	omega-Chloroacetophenone (Mace)IBA 01/2023 - 01/2019
9	LipidsIBA 01/2022 - 07/2006
9	LDL CholesterolIBA 10/2021 - 06/2006
8	HDL CholesterolIBA 01/2022 - 05/2002
8	Rosiglitazone (Avandia)FDA Link 05/2011 - 10/2002
7	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2024 - 01/2018
7	Acarbose FDA LinkGeneric 11/2023 - 07/2014
7	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2022 - 07/2015
7	CreatinineIBA 01/2022 - 06/2006
7	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 10/2007
6	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2010
6	SodiumIBA 01/2023 - 10/2019
6	Glyburide (Glibenclamide)FDA LinkGeneric 05/2011 - 10/2002
5	Sodium-Glucose Transporter 2 InhibitorsIBA 02/2024 - 10/2019
5	Hemoglobins (Hemoglobin)IBA 01/2022 - 12/2013
5	ThiazolidinedionesIBA 10/2020 - 12/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 02/2014
4	empagliflozinIBA 01/2023 - 01/2020
4	Glucagon-Like Peptide-1 ReceptorIBA 12/2019 - 04/2016
4	Triglycerides (Triacylglycerol)IBA 01/2018 - 01/2004
4	C-Reactive ProteinIBA 02/2014 - 10/2002
4	AlbuminsIBA 01/2012 - 10/2002
3	Glycoside Hydrolase InhibitorsIBA 11/2023 - 01/2018
3	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 11/2022
3	Blood Glucose (Blood Sugar)IBA 07/2020 - 02/2014
3	GlucosidasesIBA 01/2020 - 07/2014
3	Retinaldehyde (Retinal)IBA 01/2020 - 11/2002
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 03/2009
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2017 - 11/2004
3	CholesterolIBA 01/2012 - 08/2006
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2009 - 12/2006
2	SymportersIBA 01/2023 - 11/2022
2	AutoantibodiesIBA 01/2020 - 11/2006
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2019 - 01/2017
2	Angiotensin Receptor AntagonistsIBA 09/2017 - 10/2012
2	Fibrinogen (Factor I)FDA Link 08/2006 - 10/2002
2	AntigensIBA 08/2006 - 10/2002
1	Sodium-Glucose Transport ProteinsIBA 02/2024
1	OsteocalcinIBA 07/2023
1	OsteopontinIBA 07/2023
1	OsteoprotegerinIBA 07/2023
1	Pioglitazone (Actos)FDA Link 01/2023
1	CanagliflozinIBA 01/2023

Therapy/Procedure

40	Therapeutics 02/2024 - 02/2002
11	Glycemic Control 01/2020 - 02/2002
5	Precision Medicine 02/2024 - 01/2018
5	Surgical Amputation (Amputations) 10/2021 - 06/2013
4	Light Coagulation 01/2020 - 11/2002
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2006
2	Secondary Prevention 11/2017 - 09/2017